UB Paderborn / Katalog / Suche / in CDI

1 – 18 von 18

Sortiert nach

Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

Journal of clinical oncology, 1993-01, Vol.11 (1), p.15-21

1993

Volltextzugriff (PDF)

New therapeutic modalities for the clinical use of rhGM-CSF in patients with malignancies

American journal of clinical oncology, 1991, Vol.14, p.S19-S26

1991

Volltextzugriff (PDF)

Phase I study with combination therapy of pirarubicin, etoposide, and vincristine in small-cell lung cancer

American journal of clinical oncology, 1990-01, Vol.13, p.S24-S28

1990

Volltextzugriff (PDF)

Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas : preliminary results of a phase II study from the EORTC soft-tissue and bone sarcoma group

Journal of cancer research and clinical oncology, 1991-01, Vol.117 (S4), p.S193-S197

1991

Volltextzugriff (PDF)

Phase I-II study on weekly administration of pirarubicin in patients with metastatic breast cancer

American journal of clinical oncology, 1990-01, Vol.13, p.S29-S39

1990

Volltextzugriff (PDF)

Differences in lung function in smokers, former smokers and nonsmokers

Praxis und Klinik der Pneumologie, 1985-05, Vol.39 (5), p.165

Greifenberg, B

1985

Volltextzugriff (PDF)

Phase II study of pirarubicin in metastatic breast cancer

Onkologie, 1990-06, Vol.13 (3), p.175

1990

Volltextzugriff (PDF)

Pharmacokinetics of 4'-O-tetrahydropyranyladriamycin given on a weekly schedule in patients with advanced breast cancer

Cancer chemotherapy and pharmacology, 1995, Vol.37 (1-2), p.91-96

1995

Volltextzugriff (PDF)

Pirarubicin (4'-O-tetrahydropyranil-adriamycin) for treatment of advanced breast cancer : a clinical phase II study

Investigational new drugs, 1990-05, Vol.8 (2), p.207-210

1990

Volltextzugriff (PDF)

Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors

Nature chemical biology, 2016-10, Vol.12 (10), p.876

2016

Volltextzugriff (PDF)

Myeloid-derived suppressor cell activation by combined LPS and IFN-γ treatment impairs DC development

European journal of immunology, 2009-10, Vol.39 (10), p.2865-2876

2009

Volltextzugriff (PDF)

Subsets, expansion and activation of myeloid-derived suppressor cells

Medical microbiology and immunology, 2010-08, Vol.199 (3), p.273-281

2010

Volltextzugriff (PDF)

Structure-activity relationship study of THZ531 derivatives enables the discovery of BSJ-01-175 as a dual CDK12/13 covalent inhibitor with efficacy in Ewing sarcoma

European journal of medicinal chemistry, 2021-10, Vol.221, p.113481-113481, Article 113481

2021

Volltextzugriff (PDF)

De Gruyter Handbook of Disability and Management

1, 2023

Volltextzugriff (PDF)

238 Reversal of primary and acquired PARP-inhibitor resistance in BRCA-mutated triple-negative breast cancers by inhibition of transcriptional cyclin-dependent kinases (CDKs)

European journal of cancer (1990), 2014-11, Vol.50, p.80-80

2014

Volltextzugriff (PDF)

Subsets, expansion and activation of myeloid-derived suppressor cells: Pathogen Variation and Host Response in Infectious Disease

Medical microbiology and immunology, 2010, Vol.199 (3), p.273-281

2010

Volltextzugriff (PDF)

Synuclein Protein Levels Are Increased in Alcoholic Patients and Are Linked to Craving

Alcoholism, clinical and experimental research, 2005-05, Vol.29 (5), p.763-765

2005

Volltextzugriff (PDF)

Mastering the future: Agile model-based system design for BMW’s electrified next generation platform

18. Internationales Stuttgarter Symposium, 2018, p.1365-1376

2018

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(15)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(11)
Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Female
(9)
Adult
(8)
Biological And Medical Sciences
(8)
Aged
(7)
Medical Sciences
(7)
Middle Aged
(7)
Oncology
(7)
Pharmacology. Drug Treatments
(7)
Antineoplastic Agents
(6)
Chemotherapy
(5)
Doxorubicin - Administration & Dosage
(5)
Doxorubicin - Analogs & Derivatives
(5)
Drug Evaluation
(5)
Male
(5)
Breast Neoplasms - Drug Therapy
(4)
Remission Induction
(4)
Animals
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

New therapeutic modalities for the clinical use of rhGM-CSF in patients with malignancies

Phase I study with combination therapy of pirarubicin, etoposide, and vincristine in small-cell lung cancer

Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas : preliminary results of a phase II study from the EORTC soft-tissue and bone sarcoma group

Phase I-II study on weekly administration of pirarubicin in patients with metastatic breast cancer

Differences in lung function in smokers, former smokers and nonsmokers

Phase II study of pirarubicin in metastatic breast cancer

Pharmacokinetics of 4'-O-tetrahydropyranyladriamycin given on a weekly schedule in patients with advanced breast cancer

Pirarubicin (4'-O-tetrahydropyranil-adriamycin) for treatment of advanced breast cancer : a clinical phase II study

Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors

Myeloid-derived suppressor cell activation by combined LPS and IFN-γ treatment impairs DC development

Subsets, expansion and activation of myeloid-derived suppressor cells

Structure-activity relationship study of THZ531 derivatives enables the discovery of BSJ-01-175 as a dual CDK12/13 covalent inhibitor with efficacy in Ewing sarcoma

De Gruyter Handbook of Disability and Management

238 Reversal of primary and acquired PARP-inhibitor resistance in BRCA-mutated triple-negative breast cancers by inhibition of transcriptional cyclin-dependent kinases (CDKs)

Subsets, expansion and activation of myeloid-derived suppressor cells: Pathogen Variation and Host Response in Infectious Disease

Synuclein Protein Levels Are Increased in Alcoholic Patients and Are Linked to Craving

Mastering the future: Agile model-based system design for BMW’s electrified next generation platform

Suchergebnisse filtern